113 filings
8-K
SNSE
Sensei Biotherapeutics, Inc.
20 Sep 24
Departure of Directors or Certain Officers
4:31pm
10-Q
2024 Q2
SNSE
Sensei Biotherapeutics, Inc.
Quarterly report
6 Aug 24
4:30pm
8-K
SNSE
Sensei Biotherapeutics, Inc.
6 Aug 24
Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
7:36am
8-K
SNSE
Sensei Biotherapeutics, Inc.
12 Jul 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:31pm
8-K
SNSE
Sensei Biotherapeutics, Inc.
27 Jun 24
Departure of Directors or Certain Officers
5:01pm
8-K
ns67wafg7lpd 9b
13 Jun 24
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
i10b31 4r
3 Jun 24
Regulation FD Disclosure
7:31am
8-K
qu67n yno6r8rrsh
23 May 24
Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
5:10pm
8-K
9b9wuui9n 23sbe8
9 May 24
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
7:37am
ARS
nuilf2ck5assjgev du
29 Apr 24
Annual report to shareholders
4:40pm
DEFA14A
q15ego8
29 Apr 24
Additional proxy soliciting materials
4:35pm
8-K
o3nu6 urgn7v3
12 Apr 24
Departure of Directors or Certain Officers
4:31pm
8-K
ahwsh
2 Apr 24
Departure of Directors or Certain Officers
7:45am
8-K
dwou8eib d25vogh4
5 Mar 24
Entry into a Material Definitive Agreement
4:44pm
S-8
lm63h0j7
29 Feb 24
Registration of securities for employees
4:44pm
8-K
wlci3tbvk nj
28 Feb 24
Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
7:31am
8-K
144zro gkty0uo
8 Feb 24
Departure of Directors or Certain Officers
4:31pm